Cargando…

Single-platelet nanomechanics measured by high-throughput cytometry

Haemostasis occurs at sites of vascular injury, where flowing blood forms a clot, a dynamic and heterogeneous fibrin-based biomaterial. Paramount in the clot’s capability to stem haemorrhage are its changing mechanical properties, the major driver of which are the contractile forces exerted by plate...

Descripción completa

Detalles Bibliográficos
Autores principales: Myers, David R., Qiu, Yongzhi, Fay, Meredith E., Tennenbaum, Michael, Chester, Daniel, Cuadrado, Jonas, Sakurai, Yumiko, Baek, Jong, Tran, Reginald, Ciciliano, Jordan, Ahn, Byungwook, Mannino, Robert, Bunting, Silvia, Bennett, Carolyn, Briones, Michael, Fernandez-Nieves, Alberto, Smith, Michael L., Brown, Ashley C., Sulchek, Todd, Lam, Wilbur A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266633/
https://www.ncbi.nlm.nih.gov/pubmed/27723740
http://dx.doi.org/10.1038/nmat4772
Descripción
Sumario:Haemostasis occurs at sites of vascular injury, where flowing blood forms a clot, a dynamic and heterogeneous fibrin-based biomaterial. Paramount in the clot’s capability to stem haemorrhage are its changing mechanical properties, the major driver of which are the contractile forces exerted by platelets against the fibrin scaffold (1). However, how platelets transduce microenvironmental cues to mediate contraction and alter clot mechanics is unknown. This is clinically relevant, as overly softened and stiffened clots are associated with bleeding (2) and thrombotic disorders (3). Here, we report a high-throughput hydrogel based platelet-contraction cytometer that quantifies single-platelet contraction forces in different clot microenvironments. We also show that platelets, via the Rho/ROCK pathway, synergistically couple mechanical and biochemical inputs to mediate contraction. Moreover, highly contractile platelet subpopulations present in healthy controls are conspicuously absent in a subset of patients with undiagnosed bleeding disorders, and therefore may function as a clinical diagnostic biophysical biomarker.